Daiichi Sankyo completes Zenotech offer amid claims from founder
This article was originally published in Scrip
Executive Summary
The founder of the Indian biotech firm, Zenotech Laboratories, claims that Daiichi Sankyo has rejected the bulk of his shares that were tendered in the Japanese company's recently concluded open offer for an additional 20% of Zenotech.